Your browser doesn't support javascript.
loading
Neutralizing Antibodies to SARS-CoV-2 Selected from a Human Antibody Library Constructed Decades Ago.
Qiang, Min; Ma, Peixiang; Li, Yu; Liu, Hejun; Harding, Adam; Min, Chenyu; Wang, Fulian; Liu, Lili; Yuan, Meng; Ji, Qun; Tao, Pingdong; Shi, Xiaojie; Li, Zhean; Li, Teng; Wang, Xian; Zhang, Yu; Wu, Nicholas C; Lee, Chang-Chun D; Zhu, Xueyong; Gilbert-Jaramillo, Javier; Zhang, Chuyue; Saxena, Abhishek; Huang, Xingxu; Wang, Hou; James, William; Dwek, Raymond A; Wilson, Ian A; Yang, Guang; Lerner, Richard A.
Afiliação
  • Qiang M; Shanghai Institute for Advanced Immunochemical Studies, ShanghaiTech University, Shanghai, 201210, P. R. China.
  • Ma P; Shanghai Institute for Advanced Immunochemical Studies, ShanghaiTech University, Shanghai, 201210, P. R. China.
  • Li Y; Shanghai Institute for Advanced Immunochemical Studies, ShanghaiTech University, Shanghai, 201210, P. R. China.
  • Liu H; School of Life Science and Technology, ShanghaiTech University, Shanghai, 201210, P. R. China.
  • Harding A; Institute of Biochemistry and Cell Biology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai, 200031, P. R. China.
  • Min C; University of Chinese Academy of Sciences, Beijing, 100049, P. R. China.
  • Wang F; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA, 92037, USA.
  • Liu L; Sir William Dunn School of Pathology, University of Oxford, Oxford, OX1 3RE, UK.
  • Yuan M; Velox Pharmaceuticals, Changzhou, 213000, P. R. China.
  • Ji Q; Shanghai Institute for Advanced Immunochemical Studies, ShanghaiTech University, Shanghai, 201210, P. R. China.
  • Tao P; School of Life Science and Technology, ShanghaiTech University, Shanghai, 201210, P. R. China.
  • Shi X; Institute of Biochemistry and Cell Biology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai, 200031, P. R. China.
  • Li Z; University of Chinese Academy of Sciences, Beijing, 100049, P. R. China.
  • Li T; Shanghai Institute for Advanced Immunochemical Studies, ShanghaiTech University, Shanghai, 201210, P. R. China.
  • Wang X; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA, 92037, USA.
  • Zhang Y; Shanghai Institute for Advanced Immunochemical Studies, ShanghaiTech University, Shanghai, 201210, P. R. China.
  • Wu NC; Shanghai Institute for Advanced Immunochemical Studies, ShanghaiTech University, Shanghai, 201210, P. R. China.
  • Lee CD; School of Life Science and Technology, ShanghaiTech University, Shanghai, 201210, P. R. China.
  • Zhu X; Institute of Biochemistry and Cell Biology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai, 200031, P. R. China.
  • Gilbert-Jaramillo J; University of Chinese Academy of Sciences, Beijing, 100049, P. R. China.
  • Zhang C; Shanghai Institute for Advanced Immunochemical Studies, ShanghaiTech University, Shanghai, 201210, P. R. China.
  • Saxena A; Shanghai Institute for Advanced Immunochemical Studies, ShanghaiTech University, Shanghai, 201210, P. R. China.
  • Huang X; Shanghai Institute for Advanced Immunochemical Studies, ShanghaiTech University, Shanghai, 201210, P. R. China.
  • Wang H; School of Life Science and Technology, ShanghaiTech University, Shanghai, 201210, P. R. China.
  • James W; Institute of Biochemistry and Cell Biology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai, 200031, P. R. China.
  • Dwek RA; University of Chinese Academy of Sciences, Beijing, 100049, P. R. China.
  • Wilson IA; Shanghai Institute for Advanced Immunochemical Studies, ShanghaiTech University, Shanghai, 201210, P. R. China.
  • Yang G; School of Life Science and Technology, ShanghaiTech University, Shanghai, 201210, P. R. China.
  • Lerner RA; Institute of Biochemistry and Cell Biology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai, 200031, P. R. China.
Adv Sci (Weinh) ; 9(1): e2102181, 2022 01.
Article em En | MEDLINE | ID: mdl-34716683
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Anticorpos Neutralizantes / Glicoproteína da Espícula de Coronavírus / Enzima de Conversão de Angiotensina 2 / SARS-CoV-2 Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Adv Sci (Weinh) Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Anticorpos Neutralizantes / Glicoproteína da Espícula de Coronavírus / Enzima de Conversão de Angiotensina 2 / SARS-CoV-2 Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Adv Sci (Weinh) Ano de publicação: 2022 Tipo de documento: Article